24HrDoc, Inc. dba 24HrDoc
FDA issued a warning letter to 24HrDoc, Inc. (Houston, TX) on February 20, 2026, after reviewing the company's website in December 2025 and finding false or misleading claims related to compounded semaglutide and tirzepatide products. The website falsely implied 24HrDoc was the compounder of the drugs by displaying its name on product labels, and made claims that the compounded products contained the 'same ingredients' as FDA-approved brand-name drugs (Ozempic, Wegovy, Mounjaro, Zepbound), which FDA found misleadingly implied FDA approval or evaluation for safety and effectiveness. The products were deemed misbranded under FDCA sections 502(a) and 502(bb), with their interstate commerce introduction constituting a prohibited act under section 301(a). FDA required a written response within 15 working days describing corrective steps, and warned that failure to comply may result in seizure or injunction.
Flagged claims (3)
Same ingredients as: Ozempic and Wegovy
The compounded semaglutide and tirzepatide products displayed on your website identify "24HrDoc" on the pictured label, suggesting 24HrDoc is the compounder of those drugs when in fact it is not.
Same ingredients as: Mounjaro and Zepbound
Required actions (3)
Within fifteen (15) working days of receipt of this letter, please provide a written response to the Office of Compounding Quality and Compliance (OCQC) within the Center for Drug Evaluation and Research (CDER)'s Office of Compliance describing the specific steps you have taken to address any violations.
Addressing the basis for other website claims that could be construed as false or misleading or demonstrating that such claims have been modified or removed in light of FDCA §§ 502(a) and 502(bb)) [21 U.S.C. §§ 352(a) and (bb)].
Failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most glp-1 / weight loss sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker